
CDC Vaccine Schedule Update Sparks Concern Among Infection Prevention Professionals, Survey Finds Communication and Confidence Gaps
Infection prevention professionals are weighing in on the CDC’s updated vaccine schedule. An ICT survey reveals mixed familiarity, rising patient questions, and a strong call for clearer guidance and communication tools. Here’s what IPC leaders say about implementation, confidence, and the real-world impact of vaccine policy changes.
When the CDC released its updated vaccine schedule, Infection Control Today® (ICT®) conducted a survey to understand how infection prevention and control (IPC) professionals are interpreting the change and how it is affecting operations on the ground. The results reveal a community that is engaged, thoughtful, and seeking clarity. Many are also deeply unsettled.
Of the respondents, more than 55% are infection preventionists, 12% are IPC leadership, 9% are nurses, and more than 24% noted “other,” such as health and safety officers, vaccine program managers, vaccine/IP coordinators, student pharmacy technicians, and authors. The breadth of roles underscores how widely vaccine guidance touches clinical practice.
The tone of many responses was striking. One respondent wrote, “Overall, changes to the CDC [are] detrimental. New trend following. Political conspiracy theories that are not backed by science but are being portrayed as fact [are] a huge betrayal and seriously degrade public and international trust.
Another respondent went further: “The current head of [United States Department of Health and Human Services] and his uneducated team is a joke. He knows as much about patent safety as the man in the moon. It’s disgraceful and dangerous that he is in such a position.”
Familiarity with the updated schedule varies. About 30% of respondents described themselves as “very familiar” with the changes, while 42 % reported being “somewhat familiar.” Another 21% said they were aware of the update but had not yet reviewed the details. These numbers suggest that while most IPC professionals are aware of the revision, the depth of engagement differs significantly.
That distinction matters. IPC teams often serve as translators between federal guidance and frontline clinical practice. When familiarity is uneven, implementation and messaging can become inconsistent across units or facilities.
Some respondents expressed frustration with how information has been communicated. “It seems like they want to tell us there are changes but are not giving us what those changes are or how we should implement them to stay in compliance with regulations,” one respondent wrote. “But they have no problem citing us when we are not in compliance. I would like to see a clean cut, “This is what your new recommendations should be, and this is why, and this education for your staff and families. We should not have to go on a Skype hunt to find this information like it is a big secret.”
Only 27% indicated that the updated vaccine recommendations had been communicated to IPC personnel, either very clearly or somewhat clearly. One respondent, however, said, “We continue mandating Hepatitis B vaccine.” Others stressed that clarity about the scientific rationale behind updates is essential for effective communication with staff and patients. As one respondent wrote, “Removing science and basic epidemiology from vaccine guidance confuses patients.”
Operationally, the update appears to have ripple effects. More than 55% of respondents noted increased patient questions following the announcement. Vaccine schedules are not abstract policy documents; they are live conversations in exam rooms, employee health offices, and community clinics. When schedules evolve, so does the demand for reassurance and education.
“We are seeing more cases of vaccine preventable diseases in our hospitals and a reluctance to be vaccinated due to confusing recommendations,” one respondent wrote.
Infection prevention professionals reported the need to strengthen internal education efforts. Over 45% said they wanted more formal IPC representation in advisory processes. Almost 25% said that more frequent communication with IPC professionals should happen before more vaccine discussions and changes are made. More than 21% said that better feedback mechanisms and policy changes should be incorporated into future vaccine policy discussions. This includes developing staff talking points, updating policy language, and reviewing workflow alignment. In many cases, the update has prompted teams to revisit how they communicate about vaccines more broadly.
Concerns surfaced around potential confusion. More than 81% of respondents said they are either very or moderately concerned that these routine vaccine recommendations could affect the vaccine confidence among patients or families. Respondents acknowledged the risk that updates could be misinterpreted, particularly in environments already saturated with misinformation. Infection preventionists recognize their role as trusted voices. Maintaining public confidence requires proactive, consistent messaging. As one respondent wrote, There is “increased hesitancy. Increased incidence of previously irradiated disease.”
The concern and emotional toll rang in the words from this respondent, “It’s made me angry. Medical professionals and researchers have devoted their lives to this field, only to be discredited by someone with no clinical knowledge or education.”
Despite the frustration, many IPC professionals remain confident in their ability to respond. Over 63% reported being very or somewhat confident in addressing patient concerns. Still, respondents emphasized the need for stronger structural support. More than 45% said they want more formal IPC representation in advisory processes. Nearly 25% called for more frequent communication with IPC professionals before vaccine discussions and changes are made. More than 21% advocated for better feedback mechanisms and policy integration into future vaccine decision making.
Respondents consistently identified 3 areas of support that would help: concise CDC summaries that distill complex updates into actionable points, patient facing educational materials that address common concerns, and coordinated messaging across leadership levels to ensure consistency.
One notable takeaway is the central role of infection prevention professionals as bridges between policy and practice. They are responsible not only for interpreting guidelines but also for safeguarding confidence in preventive strategies. This dual responsibility requires both scientific literacy and communication skills.
One respondent said, “Recommendations are just that—recommendations. We have the relationships with clinical collaborators to encourage presenting-patient centered care.”
The survey underscores a broader reality. Vaccine schedule updates intersect with trust, communication, and operational readiness. IPC professionals are not only implementing guidance. They are safeguarding confidence in preventive strategies.
One respondent captured the depth of apprehension: “It is extremely concerning that our vaccine policy nationally seems to have been usurped by those with views outside the mainstream and antivax crackpots.”
While familiarity with the CDC update is widespread, the survey suggests that clarity, transparency, and partnership will determine how effectively these changes are adopted and communicated. IPC professionals are asking not only for answers, but for a seat at the table where those answers are shaped.
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.



